
Delia M. Ramirez
Examiner (ID: 5669, Phone: (571)272-0938 , Office: P/1652 )
| Most Active Art Unit | 1652 |
| Art Unit(s) | 1652 |
| Total Applications | 1529 |
| Issued Applications | 829 |
| Pending Applications | 183 |
| Abandoned Applications | 540 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16557529
[patent_doc_number] => 20210002677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => SYNTHESIS OF OMEGA FUNCTIONALIZED PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 17/021338
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10939
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021338
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021338 | SYNTHESIS OF OMEGA FUNCTIONALIZED PRODUCTS | Sep 14, 2020 | Abandoned |
Array
(
[id] => 16656014
[patent_doc_number] => 20210052650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => ENGINEERED MEGANUCLEASES WITH RECOGNITION SEQUENCES FOUND IN THE HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE
[patent_app_type] => utility
[patent_app_number] => 17/016056
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33932
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17016056
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/016056 | Nucleic acids encoding engineered meganucleases with recognition sequences found in the human T cell receptor alpha constant region gene | Sep 8, 2020 | Issued |
Array
(
[id] => 16506512
[patent_doc_number] => 20200385768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => ENGINEERED IMINE REDUCTASES AND METHODS FOR THE REDUCTIVE AMINATION OF KETONE AND AMINE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/002671
[patent_app_country] => US
[patent_app_date] => 2020-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43359
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17002671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/002671 | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds | Aug 24, 2020 | Issued |
Array
(
[id] => 16513212
[patent_doc_number] => 20200392470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => NOVEL ACYLTRANSFERASES, VARIANT THIOESTERASES, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/998268
[patent_app_country] => US
[patent_app_date] => 2020-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16998268
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/998268 | NOVEL ACYLTRANSFERASES, VARIANT THIOESTERASES, AND USES THEREOF | Aug 19, 2020 | Abandoned |
Array
(
[id] => 17060128
[patent_doc_number] => 11104715
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-31
[patent_title] => Methods for producing aflibercept in chemically defined media having reduced aflibercept variants
[patent_app_type] => utility
[patent_app_number] => 16/996030
[patent_app_country] => US
[patent_app_date] => 2020-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 86
[patent_no_of_words] => 67372
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16996030
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/996030 | Methods for producing aflibercept in chemically defined media having reduced aflibercept variants | Aug 17, 2020 | Issued |
Array
(
[id] => 16557470
[patent_doc_number] => 20210002618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF ARMODAFINIL
[patent_app_type] => utility
[patent_app_number] => 16/995444
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16995444
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/995444 | Biocatalysts and methods for the synthesis of armodafinil | Aug 16, 2020 | Issued |
Array
(
[id] => 17852184
[patent_doc_number] => 20220282226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => MODIFIED HOST CELLS FOR HIGH EFFICIENCY PRODUCTION OF VANILLIN
[patent_app_type] => utility
[patent_app_number] => 17/631429
[patent_app_country] => US
[patent_app_date] => 2020-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17631429
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/631429 | Modified host cells for high efficiency production of vanillin | Jul 30, 2020 | Issued |
Array
(
[id] => 16786366
[patent_doc_number] => 10988781
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-27
[patent_title] => Method of target cleaving using CRISPR hybrid DNA/RNA polynucleotides
[patent_app_type] => utility
[patent_app_number] => 16/941130
[patent_app_country] => US
[patent_app_date] => 2020-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 18
[patent_no_of_words] => 24900
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16941130
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/941130 | Method of target cleaving using CRISPR hybrid DNA/RNA polynucleotides | Jul 27, 2020 | Issued |
Array
(
[id] => 18685459
[patent_doc_number] => 11781182
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-10
[patent_title] => Modified polymerases for improved incorporation of nucleotide analogues
[patent_app_type] => utility
[patent_app_number] => 16/929632
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 5
[patent_no_of_words] => 10278
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16929632
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/929632 | Modified polymerases for improved incorporation of nucleotide analogues | Jul 14, 2020 | Issued |
Array
(
[id] => 17649590
[patent_doc_number] => 11352304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-07
[patent_title] => Bacterial consortia for enhancing conversion of organic soil phosphorous to orthophosphate and methods for making and using same
[patent_app_type] => utility
[patent_app_number] => 16/927734
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 35
[patent_no_of_words] => 11854
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927734
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927734 | Bacterial consortia for enhancing conversion of organic soil phosphorous to orthophosphate and methods for making and using same | Jul 12, 2020 | Issued |
Array
(
[id] => 16375075
[patent_doc_number] => 20200323917
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => DNASE1-LIKE 3 AND ITS USE IN THERAPY
[patent_app_type] => utility
[patent_app_number] => 16/915547
[patent_app_country] => US
[patent_app_date] => 2020-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12422
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16915547
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/915547 | Methods of using DNASE1-like 3 in therapy | Jun 28, 2020 | Issued |
Array
(
[id] => 16870530
[patent_doc_number] => 20210163997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-03
[patent_title] => METHOD OF CREATING RECOMBINANT MICROORGANISM FOR MANUFACTURING FERMENTATION PRODUCT
[patent_app_type] => utility
[patent_app_number] => 16/913232
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913232 | METHOD OF CREATING RECOMBINANT MICROORGANISM FOR MANUFACTURING FERMENTATION PRODUCT | Jun 25, 2020 | Abandoned |
Array
(
[id] => 16361337
[patent_doc_number] => 20200318088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Engineered Nucleic-Acid Targeting Nucleic Acids
[patent_app_type] => utility
[patent_app_number] => 16/907115
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31301
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16907115
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/907115 | Engineered nucleic-acid targeting nucleic acids | Jun 18, 2020 | Issued |
Array
(
[id] => 16326011
[patent_doc_number] => 20200296976
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => Enzyme exhibiting fructan hydrolase activity
[patent_app_type] => utility
[patent_app_number] => 16/899611
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7351
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899611
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899611 | Enzyme exhibiting fructan hydrolase activity | Jun 11, 2020 | Issued |
Array
(
[id] => 17815590
[patent_doc_number] => 11421189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Automatic dishwashing detergent composition
[patent_app_type] => utility
[patent_app_number] => 16/876328
[patent_app_country] => US
[patent_app_date] => 2020-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9255
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16876328
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/876328 | Automatic dishwashing detergent composition | May 17, 2020 | Issued |
Array
(
[id] => 16375142
[patent_doc_number] => 20200323984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => DELIVERY SYSTEM FOR FUNCTIONAL NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 16/860639
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860639
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860639 | DELIVERY SYSTEM FOR FUNCTIONAL NUCLEASES | Apr 27, 2020 | Pending |
Array
(
[id] => 19855786
[patent_doc_number] => 12258610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Production of chemicals from renewable sources
[patent_app_type] => utility
[patent_app_number] => 17/605389
[patent_app_country] => US
[patent_app_date] => 2020-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 6
[patent_no_of_words] => 77576
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605389
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605389 | Production of chemicals from renewable sources | Apr 24, 2020 | Issued |
Array
(
[id] => 16013501
[patent_doc_number] => 20200181593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES
[patent_app_type] => utility
[patent_app_number] => 16/798629
[patent_app_country] => US
[patent_app_date] => 2020-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18875
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 177
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16798629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/798629 | ALPHA-AMYLASE VARIANT WITH ALTERED PROPERTIES | Feb 23, 2020 | Abandoned |
Array
(
[id] => 15994151
[patent_doc_number] => 20200172946
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-04
[patent_title] => Production of Glucose Syrups
[patent_app_type] => utility
[patent_app_number] => 16/788950
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29470
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788950
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788950 | Production of Glucose Syrups | Feb 11, 2020 | Abandoned |
Array
(
[id] => 16013487
[patent_doc_number] => 20200181586
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => COMPOSITIONS AND METHODS FOR PROTEIN GLYCOSYLATION
[patent_app_type] => utility
[patent_app_number] => 16/785819
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16785819
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/785819 | Compositions and methods for protein glycosylation | Feb 9, 2020 | Issued |